Axsome's depression drug enters competitive market after US approval
August 19, 2022 at 11:58 AM EDT
the Food and Drug Administration approved Axsome Therapeutics anti-depression drug Auvelity which reduces symptions as early as one week.
Photography by Christophe Tomatis